“Off-the-Shelf” CAR T-Cell Therapy Shows Mixed Early Results

A Phase I study for a base edited 'off-the-shelf' CAR T-cell therapy for treatment of acute myeloid leukemia (AML) showed mixed safety and efficacy results.